TD Waterhouse Canada’s Oruka Therapeutics ORKA Stock Holding History

TD Waterhouse Canada’s Portfolio ORKA Stock Details ORKA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-108	Closed	-$2.63K	–	1816
2023 Q2	$2.63K	Hold	108	–	–	﹤0.01%	1504
2023 Q1	$2.54K	Hold	108	–	–	﹤0.01%	1488
2022 Q4	$3.13K	Hold	108	–	–	﹤0.01%	1430
2022 Q3	$2.7K	Hold	108	–	–	﹤0.01%	1462
2022 Q2	$3.21K	Hold	108	–	–	﹤0.01%	1469
2022 Q1	$2.86K	Hold	108	–	–	﹤0.01%	1543
2021 Q4	$2.89K	Buy	+108	New	+$3.25K	﹤0.01%	1532

Other funds holding ORKA

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TD Waterhouse Canada's ORKA Position: Q3 2023 in Review

TD Waterhouse Canada sold out of Oruka Therapeutics (ORKA) in Q3 2023, closing a stake of 108 shares — an estimated $2.63K sold.

TD Waterhouse Canada first reported a position in ORKA in Q4 2021 and held it in 7 quarters. The position peaked at $3.21K in Q2 2022. 21 funds tracked by Wall St. Rank hold ORKA as of Q3 2023.

TD Waterhouse Canada reported no remaining Oruka Therapeutics position as of Q3 2023 after selling out during the quarter.
TD Waterhouse Canada sold 108 Oruka Therapeutics shares in Q3 2023, an estimated $2.63K.
TD Waterhouse Canada first reported a position in Oruka Therapeutics in Q4 2021 and held it in 7 quarters.
TD Waterhouse Canada's Oruka Therapeutics position peaked at $3.21K in Q2 2022.
21 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2023.

Based on TD Waterhouse Canada's 13F filing for Q3 2023, filed 13 Nov 2023.